Antibodies to anti-thymocyte globulin in aplastic anemia patients have a negative impact on hematopoietic SCT


Severe aplastic anemia (SAA) is a life threatening BM failure and the preferred therapy for children is allogeneic hematopoietic SCT (HSCT) with an HLA-matched sibling donor. Immunosuppressive therapy with anti-thymocyte globulin (ATG) and CsA is an alternative for patients lacking an HLA-identical donor. For many years, horse ATG (hATG) was the preferred… (More)
DOI: 10.1038/bmt.2011.259

1 Figure or Table


  • Presentations referencing similar topics